Issue: Volume XIV No. 17 - December 10, 2007

Building the Better Mousetrap for Lab Outreach

IS THERE A BLUEPRINT for building a thriving, successful hospital outreach program in a new market? If so, it would certainly be a best seller among hospitals seeking new sources of revenues and profits from outreach testing. While it’s not exactly a blueprint, Pathology Associates Medical Laboratories (PAML) of Spokane, Washington, has developed both a unique strategy and …

Building the Better Mousetrap for Lab Outreach Read More »

Busy Year Demonstrated By Top Ten Lab Stories

CEO SUMMARY: As it turns out, 2007 has been an action-packed year with lots of events, plenty of changes, and the promise of even faster evolution across all sectors of the lab testing marketplace. THE DARK REPORT’S “Top Ten Lab Stories of 2007” show the full intensity and pace of activity within laboratory medicine. One big driver in …

Busy Year Demonstrated By Top Ten Lab Stories Read More »

How PAML Built a Major Business In Lab Joint Ventures with Hospitals

 “A well-structured laboratory joint venture helps the hospital partner tap the unrealized value of its laboratory, because the independent lab partner provides capital, along with experience, and expertise to serve and build outreach market share.” —Thomas Tiffany, Ph.D., CEO, Pathology Associates Medical Laboratories CEO SUMMARY: Earlier this month, MountainStar Healthcare Network of Salt Lake City, …

How PAML Built a Major Business In Lab Joint Ventures with Hospitals Read More »

Medicare Demo Bidders’ Meeting Reveals Many Problems Ahead

LAST WEDNESDAY IN SAN DIEGO, the Centers for Medicare & Medicaid (CMS) conducted an all-day information session for laboratories interested in submitting bids to participate in the Medicare Clinical Laboratory Services Competitive Demonstration Project. It is estimated that a crowd of 100 showed up. More listened in, using a special telephone link to the Bidders’ Conference. In what could be …

Medicare Demo Bidders’ Meeting Reveals Many Problems Ahead Read More »

Integrated In Vivo-In Vitro: Is It Pathology’s Future?

CEO SUMMARY: Across the globe, forward-thinking pathologists and radiologists are taking steps to use molecular technologies in ways that combine in vivo and in vitro testing. As this happens, traditional roles for pathology and radiology are likely to evolve toward a more integrated diagnostic service. To learn more about this trend, Molecular Summit 2008 is …

Integrated In Vivo-In Vitro: Is It Pathology’s Future? Read More »

Dark Daily

December 10, 2007 “Intelligence: Late Breaking Lab News”

Last month, Beckman Coulter, Inc., of Fullerton, California, announced that it will acquire the research flow cytometry instrumentation business of Dako Denmark A/S, of Glostrup, Denmark. The move strengthens Beckman’s product line in the research market. Sale of Dako’s flow cytometry division, which is based in Fort Collins, Colorado, is a step to concentrate efforts on molecular …

December 10, 2007 “Intelligence: Late Breaking Lab News” Read More »

Powered by Americaneagle.com

Hosted by Americaneagle.com, Inc.